Cymat Technologies OTC Stock Top Insiders

CYMHF Stock  USD 0.13  0.00  0.00%   
Cymat Technologies employs about 12 people. The company is managed by 12 executives with a total tenure of roughly 130 years, averaging almost 10.0 years of service per executive, having 1.0 employees per reported executive. Examination of Cymat Technologies' management performance can provide insight into the company performance.
Michael Liik  Chairman
Executive Chairman of the Board, CEO
Kevin Smith  President
Vice President - Business Development
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cymat Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Cymat Technologies Management Team Effectiveness

The company has return on total asset (ROA) of (0.5507) % which means that it has lost $0.5507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.4124) %, meaning that it generated substantial loss on money invested by shareholders. Cymat Technologies' management efficiency ratios could be used to measure how well Cymat Technologies manages its routine affairs as well as how well it operates its assets and liabilities.

Cymat Technologies Workforce Comparison

Cymat Technologies is number one stock in number of employees category among related companies. The total workforce of Materials industry is currently estimated at about 93,551. Cymat Technologies adds roughly 12.0 in number of employees claiming only tiny portion of all equities under Materials industry.
The company has Profit Margin (PM) of (1.47) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.35) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.35.

Cymat Technologies Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Cymat Technologies Price Series Summation is a cross summation of Cymat Technologies price series and its benchmark/peer.

Cymat Technologies Notable Stakeholders

A Cymat Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cymat Technologies often face trade-offs trying to please all of them. Cymat Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cymat Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael LiikExecutive Chairman of the Board, CEOProfile
Kevin SmithVice President - Business DevelopmentProfile
William PettipasIndependent DirectorProfile
Martin MazzaIndependent DirectorProfile
Lewis MacKenzieIndependent DirectorProfile
Jon GillIndependent DirectorProfile
Jim JohnsonVP of OperationsProfile
Darryl KleebaumChief OfficerProfile
Mario DeAngelisChief OfficerProfile
Vince BenincasaChief OfficerProfile
David HenryHead DevelProfile
P MBAEx CEOProfile

About Cymat Technologies Management Performance

The success or failure of an entity such as Cymat Technologies often depends on how effective the management is. Cymat Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cymat management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cymat management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company was incorporated in 2006 and is based in Mississauga, Canada. Cymat Technologies is traded on OTC Exchange in the United States.
The data published in Cymat Technologies' official financial statements usually reflect Cymat Technologies' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cymat Technologies. For example, before you start analyzing numbers published by Cymat accountants, it's critical to develop an understanding of what Cymat Technologies' liquidity, profitability, and earnings quality are in the context of the Metals & Mining space in which it operates.
Please note, the presentation of Cymat Technologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cymat Technologies' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cymat Technologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cymat Technologies. Please utilize our Beneish M Score to check the likelihood of Cymat Technologies' management manipulating its earnings.

Cymat Technologies Workforce Analysis

Traditionally, organizations such as Cymat Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cymat Technologies within its industry.

Cymat Technologies Manpower Efficiency

Return on Cymat Technologies Manpower

Revenue Per Employee260.3K
Revenue Per Executive260.3K
Net Loss Per Employee395.5K
Net Loss Per Executive395.5K
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cymat Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Cymat Technologies information on this page should be used as a complementary analysis to other Cymat Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Cymat OTC Stock analysis

When running Cymat Technologies' price analysis, check to measure Cymat Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cymat Technologies is operating at the current time. Most of Cymat Technologies' value examination focuses on studying past and present price action to predict the probability of Cymat Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cymat Technologies' price. Additionally, you may evaluate how the addition of Cymat Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Please note, there is a significant difference between Cymat Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cymat Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cymat Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.